[Skip to Content]
[Skip to Content Landing]
December 6, 1995

Incorrect Data.

JAMA. 1995;274(21):1676. doi:10.1001/jama.1995.03530210030025

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


—In the Original Contribution entitled "Effects of Estrogen or Estrogen/Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/ Progestin Interventions (PEPI) Trial," published in the January 18, 1995, issue of The Journal (1995;273:199-208), some dual-reported triglyceride levels and a fibrinogen level were incorrect. In Table 1, the triglyceride values should be 1.12±0.04 mmol/L (99.0±3.3 mg/dL) for placebo, 1.11±0.04 mmol/L (98.7±3.4 mg/dL) for CEE only, 1.06±0.03 mmol/L (94.3±2.9 mg/dL) for CEE + MPA (cyc), 1.16±0.04 mmol/L (102.7±3.6 mg/dL) for CEE + MPA (con), and 1.10±0.04 mmol/L (97.5±3.4 mg/dL) for CEE + MP (cyc). On page 200, third column, second paragraph, the text should read "level of 5.6 mmol/L (500 mg/ dL)"; on page 203, first column, third paragraph, "a mean of 1.11 mmol/L (98.3 mg/dL) to 1.25 mmol/L (111 mg/dL)"; and on page 205, second column, last paragraph, "less than 5.6 mmol/L (500 mg/dL)." Also, in Table 2, the fibrinogen

First Page Preview View Large
First page PDF preview
First page PDF preview